ABBV vs MSFT
AbbVie Inc. vs Microsoft Corporation
ABBV
AbbVie Inc.
$232.03+3.27%
MSFT
Microsoft Corporation
$392.74-2.24%
Key Metrics Comparison
| ABBV | Metric | MSFT |
|---|---|---|
| $232.03 | Price | $392.74 |
| $410.09B | Market Cap | $2.92TBetter |
| 98.74 | P/E Ratio | 24.58Better |
| $2.35 | EPS | $15.98Better |
| +3.27%Better | Day Change | -2.24% |
| $244.81 | 52W High | $555.45 |
| $164.39 | 52W Low | $344.79 |
| 4,213,578 | Volume | 41,581,101Better |
| 6,401,624 | Avg Volume | 32,834,928Better |
About AbbVie Inc.
Healthcare | Drug Manufacturers - General
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for th...
About Microsoft Corporation
Technology | Software - Infrastructure
Microsoft Corporation develops, licenses, and supports software, services, devices, and solutions worldwide. The company operates in three segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment offers Office, Exc...